People | December 20, 2022
Cadila Pharmaceuticals appoints Ashraf Allam as Global COO
Allam was serving recently as the CEO at Public Investment Fund
Allam was serving recently as the CEO at Public Investment Fund
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
Global pharmaceutical company having a surgical business concept incepted in Dubai
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
The advanced laboratory spread over 2,200 Square feet has multiple laboratory divisions including Hematology, Biochemistry, Clinical pathology, Serology and Microbiology
The product is backed by required scientific proof and comparative bioequivalence studies
Post the sale, Patel family has become the single largest promoter shareholder in the company
The Halol facility was placed under Import Alert by USFDA.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Subscribe To Our Newsletter & Stay Updated
